Phase II trial of perioperative chemotherapy of esophageal cancer: PIECE trial.

被引：0
|
作者：
Nomura, Motoo
Goto, Masahiro
Watanabe, Masayuki
Hato, Shinji
Kato, Ken
Baba, Eishi
Matsubara, Hisahiro
Mukaida, Hidenori
Yoshii, Takako
Tsuda, Masahiro
Tsubosa, Yasuhiro
Kitagawa, Yuko
Hideki, Ishikawa
Muto, Manabu
机构：
[1] Kyoto Univ Hosp, Dept Clin Oncol, Kyoto, Japan
[2] Osaka Med & Pharmaceut Univ Hosp, Ctr Canc Chemotherapy, Takatsuki, Osaka, Japan
[3] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Surg Gastroenterol, Koto Ku, Tokyo, Japan
[4] Shikoku Canc Ctr, Matsuyama, Ehime, Japan
[5] Natl Canc Ctr, Dept Gastrointestinal Med Oncol, Tokyo, Japan
[6] Kyushu Univ, Grad Sch Med Sci, Dept Oncol & Social Med, Fukuoka, Japan
[7] Chiba Univ, Chiba, Japan
[8] Hiroshima City Asa Citizens Hosp, Hiroshima, Japan
[9] Saitama Canc Ctr, Saitama, Japan
[10] Hyogo Canc Ctr, Akashi, Hyogo, Japan
[11] Shizuoka Canc Ctr, Div Esophageal Surg, Shizuoka, Japan
[12] Keio Univ, Dept Surg, Sch Med, Tokyo, Japan
[13] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Mol Targeting Canc Prevent, Kyoto, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4038
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Perioperative tislelizumab plus chemotherapy for locally advanced resectable thoracic esophageal squamous cell carcinoma trial: a prospective single-arm, phase II study (PILOT trial)
    Ding, Chengzhi
    Guo, Yijun
    Zhou, Yaning
    He, Yi
    Chen, Chunji
    Zhang, Ming
    Guo, Xufeng
    BMC CANCER, 2023, 23 (01)
  • [42] Perioperative tislelizumab plus chemotherapy for locally advanced resectable thoracic esophageal squamous cell carcinoma trial: a prospective single-arm, phase II study (PILOT trial)
    Chengzhi Ding
    Yijun Guo
    Yaning zhou
    Yi He
    Chunji Chen
    Ming Zhang
    Xufeng Guo
    BMC Cancer, 23
  • [43] Anlotinib in chemotherapy-refractory metastatic esophageal squamous cell carcinoma (ESCC): A randomized, double-blind, multicenter phase II trial.
    Huang, Jing
    Xiao, Juxiang
    Fang, Wentao
    Lu, Ping
    Fan, Qingxia
    Shu, Yongqian
    Feng, Ji Feng
    Zhang, Shu
    Ba, Yi
    Liu, Ying
    Bai, Chunmei
    Bai, Yu-Xian
    Tang, Yong
    Song, Yan
    He, Jie
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [44] Author Correction: Perioperative toripalimab and chemotherapy in locally advanced gastric or gastro-esophageal junction cancer: a randomized phase 2 trial
    Shu-Qiang Yuan
    Run-Cong Nie
    Ying Jin
    Cheng-Cai Liang
    Yuan-Fang Li
    Rui Jian
    Xiao-Wei Sun
    Ying-Bo Chen
    Wen-Long Guan
    Zi-Xian Wang
    Hai-Bo Qiu
    Wei Wang
    Shi Chen
    Dong-Sheng Zhang
    Yi-Hong Ling
    Shao-Yan Xi
    Mu-Yan Cai
    Chun-Yu Huang
    Qiu-Xia Yang
    Zhi-Min Liu
    Yuan-Xiang Guan
    Yong-Ming Chen
    Ji-Bin Li
    Xiong-Wen Tang
    Jun-Sheng Peng
    Zhi-Wei Zhou
    Rui-Hua Xu
    Feng Wang
    Nature Medicine, 2024, 30 : 605 - 605
  • [45] Long-term outcome of phase II trial evaluating chemotherapy, chemoradiotherapy, and surgery for locoregionally advanced esophageal cancer
    Swisher, SG
    Ajani, JA
    Komaki, R
    Nesbitt, JC
    Correa, AM
    Cox, JD
    Lahoti, S
    Martin, F
    Putnam, JB
    Smythe, WR
    Vaporciyan, AA
    Walsh, GL
    Roth, JA
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003, 57 (01): : 120 - 127
  • [46] A phase II trial of weekly irinotecan in cisplatin-refractory esophageal cancer
    Burkart, Christof
    Bokemeyer, Carsten
    Klump, Bodo
    Pereira, Philippe
    Teichmann, Reinhard
    Hartmann, Joerg Thomas
    ANTICANCER RESEARCH, 2007, 27 (4C) : 2845 - 2848
  • [47] Phase II trial of weekly irinotecan plus cisplatin in advanced esophageal cancer
    Ilson, DH
    Saltz, L
    Enzinger, P
    Huang, Y
    Kornblith, A
    Gollub, M
    O'Reilly, E
    Schwartz, G
    DeGroff, J
    Gonzalez, G
    Kelsen, DP
    JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (10) : 3270 - 3275
  • [48] Neoadjuvant paclitaxel poliglumex, cisplatin, and radiation for esophageal cancer: A phase II trial
    Ng, T.
    DiPetrillo, T.
    Suntharalingam, M.
    Fontaine, J.
    McNulty, B.
    Akerman, P.
    Chen, W.
    Horiba, M. N.
    Burrows, W.
    Safran, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [49] Phase II trial of docetaxel-irinotecan combination in advanced esophageal cancer
    Burtness, B.
    Gibson, M.
    Egleston, B.
    Mehra, R.
    Thomas, L.
    Sipples, R.
    Quintanilla, M.
    Lacy, J.
    Watkins, S.
    Murren, J. R.
    Forastiere, A. A.
    ANNALS OF ONCOLOGY, 2009, 20 (07) : 1242 - 1248
  • [50] Phase II trial of palbociclib in patients with advanced esophageal or gastric cancer.
    Karasic, Thomas Benjamin
    O'Hara, Mark H.
    Teitelbaum, Ursina R.
    Damjanov, Nevena
    Giantonio, Bruce J.
    d'Entremont, Tracy S.
    Gallagher, Maryann
    Zhang, Paul J.
    O'Dwyer, Peter J.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
12345